litlas
ログインアカウント作成

Aaron S. Mansfield

2009–2025 年に発表

104
論文数
18,150
被引用数
55
h 指数
100
i10 指数

被引用数

Aaron S. Mansfield の年別被引用数1989 年: 被引用 1 件2001 年: 被引用 1 件2010 年: 被引用 3 件2011 年: 被引用 2 件2012 年: 被引用 3 件2013 年: 被引用 2 件2014 年: 被引用 5 件2015 年: 被引用 10 件2016 年: 被引用 34 件2017 年: 被引用 63 件2018 年: 被引用 129 件2019 年: 被引用 615 件2020 年: 被引用 894 件2021 年: 被引用 1,158 件2022 年: 被引用 1,046 件2023 年: 被引用 921 件2024 年: 被引用 1,390 件2025 年: 被引用 819 件2026 年: 被引用 15 件1990〜2000 年は被引用が無いため表示していません2002〜2009 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,579 件、この内訳の 23.9%中国: 引用元論文 1,587 件、この内訳の 14.7%イタリア: 引用元論文 601 件、この内訳の 5.6%イギリス: 引用元論文 592 件、この内訳の 5.5%ドイツ: 引用元論文 442 件、この内訳の 4.1%日本: 引用元論文 433 件、この内訳の 4%フランス: 引用元論文 426 件、この内訳の 3.9%スペイン: 引用元論文 371 件、この内訳の 3.4%カナダ: 引用元論文 330 件、この内訳の 3.1%オーストラリア: 引用元論文 313 件、この内訳の 2.9%オランダ: 引用元論文 263 件、この内訳の 2.4%スイス: 引用元論文 250 件、この内訳の 2.3%
0%23.9%その他 24.2%

機関

分野

  • Medicine66.9%
  • Biochemistry, Genetics and Molecular Biology25.5%
  • Immunology and Microbiology2.6%
  • Computer Science1.4%
  • Engineering0.9%
  • Neuroscience0.7%
  • その他2%

トピック

  • Cancer Immunotherapy and Biomarkers8.6%
  • Lung Cancer Research Studies7.7%
  • Cancer Genomics and Diagnostics7.3%
  • Lung Cancer Treatments and Mutations6.3%
  • Neuroendocrine Tumor Research Advances2.8%
  • Immunotherapy and Immune Responses2.3%
  • その他65%

共著者

全論文

検索で開く
  1. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

    著者: Leora Horn, Aaron S. Mansfield, Aleksandra Szczęsna, Libor Havel, Maciej Krzakowski, Maximilian J. Hochmair, Florian Huemer, György Losonczy, Melissa L. Johnson, Makoto Nishio, Martin Reck, Tony Mok, Sivuonthanh Lam, David S. Shames, Juan Liu, Beiying Ding, Ariel López-Chávez, Fairooz F. Kabbinavar, Wei Lin, Alan Sandler, Stephen V. Liu - New England Journal of Medicine 2018 被引用: 3,507

  2. Detection and localization of surgically resectable cancers with a multi-analyte blood test

    著者: Joshua D. Cohen, Lu Li, Yuxuan Wang, Christopher J. Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A. Javed, Fay Wong, Austin K. Mattox, Ralph H. Hruban, Christopher L. Wolfgang, Michael Goggins, Marco Dal Molin, Tian‐Li Wang, Richard B.S. Roden, Alison P. Klein, Janine Ptak, Lisa Dobbyn, Joy Schaefer, Natalie Silliman, Maria Popoli, Joshua T Vogelstein, J. Dale Browne, Robert E. Schoen, Randall E. Brand, Jeanne Tie, Peter Gibbs, Hui‐Li Wong, Aaron S. Mansfield, Jin Jen, Samir Hanash, Massimo Falconi, Peter J. Allen, Shibin Zhou, Chetan Bettegowda, Luis A. Díaz, Cristian Tomasetti, Kenneth W. Kinzler, Bert Vogelstein, Anne Marie Lennon, Nickolas Papadopoulos - Science 2018 被引用: 2,853

  3. Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

    著者: Stephen V. Liu, Martin Reck, Aaron S. Mansfield, Tony Mok, Arnaud Scherpereel, Niels Reinmuth, Marina Chiara Garassino, Javier de Castro, Raffaele Califano, Makoto Nishio, Francesco Orlandi, Jorge Alatorre-Alexander, Ticiana Leal, Ying Cheng, Jong Seok Lee, Sivuonthanh Lam, Mark L. McCleland, Yu Deng, See Phan, Leora Horn - Journal of Clinical Oncology 2021 被引用: 824

  4. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

    著者: Paul Baas, Arnaud Scherpereel, Anna K. Nowak, Nobukazu Fujimoto, Solange Peters, Anne S. Tsao, Aaron S. Mansfield, Sanjay Popat, Thierry Jahan, Scott Antonia, Youssef Oulkhouir, Yolanda Bautista, Robin Cornelissen, Laurent Greillier, Francesco Grossi, Dariusz M. Kowalski, Jerónimo Rafael Rodríguez‐Cid, Praveen Aanur, Abderrahim Oukessou, Christine Baudelet, Gérard Zalcman - The Lancet 2021 被引用: 1,194

  5. Integrating genomic features for non-invasive early lung cancer detection

    著者: Jacob J. Chabon, Emily G. Hamilton, David M. Kurtz, Mohammad Shahrokh Esfahani, Everett J. Moding, Henning Stehr, Joseph G. Schroers‐Martin, Barzin Y. Nabet, Binbin Chen, Aadel A. Chaudhuri, Chih Long Liu, Angela BY Hui, Michael C. Jin, Tej D. Azad, Diego Almanza, Young-Jun Jeon, Monica Nesselbush, Lyron Co Ting Keh, Rene F. Bonilla, Christopher H. Yoo, Ryan B. Ko, Emily Chen, David J. Merriott, Pierre P. Massion, Aaron S. Mansfield, Jin Jen, Hong Ren, Steven H. Lin, Christina L. Costantino, Risa Burr, Robert Tibshirani, Sanjiv S. Gambhir, Gerald J. Berry, Kristin C. Jensen, Robert B. West, Joel W. Neal, Heather A. Wakelee, Billy W. Loo, Christian A. Kunder, Ann N. Leung, Natalie S. Lui, Mark F. Berry, Joseph B. Shrager, Viswam S. Nair, Daniel A. Haber, Lecia V. Sequist, Ash A. Alizadeh, Maximilian Diehn - Nature 2020 被引用: 703

  6. Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

    著者: Caicun Zhou, Kejing Tang, Byoung Chul Cho, Baogang Liu, Luis Paz‐Ares, Susanna Y. Cheng, Satoru Kitazono, Muthukkumaran Thiagarajan, Jonathan W. Goldman, Joshua K. Sabari, Rachel E. Sanborn, Aaron S. Mansfield, Jen‐Yu Hung, Michael Boyer, Sanjay Popat, Josiane Mourão Dias, Enriqueta Felip, Margarita Majem, Mahmut Gümüş, Sang‐We Kim, Akira Ono, John Xie, Archan Bhattacharya, Trishala Agrawal, S. Martin Shreeve, Roland E. Knoblauch, Keunchil Park, Nicolas Girard - New England Journal of Medicine 2023 被引用: 347

  7. Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

    著者: Justin F. Gainor, Giuseppe Curigliano, Dong‐Wan Kim, Ki Hyeong Lee, Benjamin Besse, Christina S. Baik, Robert C. Doebele, Philippe A. Cassier, Gilberto Lopes, Daniel S.W. Tan, Elena Garralda, Luis Paz‐Ares, Byoung Chul Cho, Shirish M. Gadgeel, Michael Thomas, Stephen V. Liu, Matthew H. Taylor, Aaron S. Mansfield, Viola W. Zhu, Corinne Clifford, Hui Zhang, Michael Palmer, Jennifer Green, Christopher D. Turner, Vivek Subbiah - The Lancet Oncology 2021 被引用: 443

  8. First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743

    著者: Solange Peters, Arnaud Scherpereel, Robin Cornelissen, Youssef Oulkhouir, Laurent Greillier, Kaplan Ma, Thomas Talbot, I. Monnet, Sandrine Hiret, P. Baas, Anna K. Nowak, Nobukazu Fujimoto, Anne S. Tsao, Aaron S. Mansfield, Sanjay Popat, X. Zhang, Nan Hu, David Balli, Thomas Spires, Gérard Zalcman - Annals of Oncology 2022 被引用: 263

  9. Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology

    著者: James M. Dolezal, Andrew Srisuwananukorn, Dmitry Karpeyev, Siddhi Ramesh, Sara Kochanny, Brittany Cody, Aaron S. Mansfield, Sagar Rakshit, Radhika Bansal, Melanie C. Bois, Aaron O. Bungum, Jefree J. Schulte, Everett E. Vokes, Marina Chiara Garassino, Aliya N. Husain, Alexander T. Pearson - Nature Communications 2022 被引用: 124

  10. Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years

    著者: Narjust Duma, Jesus Vera Aguilera, Jonas Paludo, Candace L. Haddox, Miguel González Vélez, Yucai Wang, Konstantinos Leventakos, Joleen M. Hubbard, Aaron S. Mansfield, Ronald S. Go, Alex A. Adjei - Journal of Oncology Practice 2017 被引用: 447

  11. Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study

    著者: Vivek Subbiah, Mimi I. Hu, Lori J. Wirth, Martin Schüler, Aaron S. Mansfield, Giuseppe Curigliano, Marcia S. Brose, Viola W. Zhu, Sophie Leboulleux, Daniel W. Bowles, Christina S. Baik, Douglas Adkins, Bhumsuk Keam, Ignacio Matos, Elena Garralda, Justin F. Gainor, Gilberto Lopes, Chia‐Chi Lin, Yann Godbert, Debashis Sarker, Stephen G. Miller, Corinne Clifford, Hui Zhang, Christopher D. Turner, Matthew H. Taylor - The Lancet Diabetes & Endocrinology 2021 被引用: 353

  12. Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

    著者: Frank Griesinger, Giuseppe Curigliano, Michael Thomas, Vivek Subbiah, Christina S. Baik, Daniel S.W. Tan, Daniel Lee, D Misch, Elena Garralda, D.-W. Kim, Anthonie J. van der Wekken, Justin F. Gainor, Luis Paz‐Ares, Stephen V. Liu, Gregory P. Kalemkerian, Yariv Houvras, Daniel W. Bowles, Aaron S. Mansfield, W. Marston Linehan, Vlatka Smoljanović, Ahmadur Rahman, Shengchun Kong, Alena Zalutskaya, Melinda Louie-Gao, Andy Boral, Julien Mazières - Annals of Oncology 2022 被引用: 178

  13. Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous EGFR -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

    著者: D. Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan W. Goldman, Fedor Moiseenko, Е. А. Филиппова, İrfan Çiçin, Tudor–Eliade Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope A. Bradbury, Mor Moskovitz, Nuran Katgı, Pascale Tomasini, Alona Zer, Nicolas Girard, Kristof Cuppens, Ji‐Youn Han, Shang‐Yin Wu, Shobhit Baijal, Aaron S. Mansfield, Chih‐Hsi S. Kuo, Kazumi Nishino, Se‐Hoon Lee, David Planchard, Christina S. Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine K. Ratajczak, Shun Lü - Journal of Clinical Oncology 2024 被引用: 135

  14. Current Diagnosis and Management of Small-Cell Lung Cancer

    著者: Shuhang Wang, Stefan Zimmermann, Kaushal Parikh, Aaron S. Mansfield, Alex A. Adjei - Mayo Clinic Proceedings 2019 被引用: 290

  15. Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial

    著者: Aaron S. Mansfield, Andrzej Każarnowicz, Nina Karaseva, A. Sánchez, Richard de Boer, Zoran Andrić, Martin Reck, Shinji Atagi, Jae‐Seong Lee, Marina Chiara Garassino, Stephen V. Liu, Leora Horn, Xiaoming Wen, Caroleen Quach, Weiguang Yu, Fairooz F. Kabbinavar, Sivuonthanh Lam, S. Morris, Raffaele Califano - Annals of Oncology 2020 被引用: 190

  16. NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

    著者: Ti Wen, Whitney Barham, Ying Li, Henan Zhang, Joanina K. Gicobi, Jacob B. Hirdler, Xin Liu, Hyoungjun Ham, Kodi E. Peterson Martinez, Fabrice Lucien, Roxane R. Lavoie, Hu Li, Cristina Correia, Dileep D. Monie, Zesheng An, Susan M. Harrington, Xiaosheng Wu, Ruifeng Guo, Roxana Dronca, Aaron S. Mansfield, Yiyi Yan, Svetomir N. Markovic, Sean S. Park, Jie Sun, Hong Qin, Minetta C. Liu, George Vasmatzis, Daniel D. Billadeau, Haidong Dong - Cancer Immunology Research 2021 被引用: 84

  17. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

    著者: Michele Carbone, Prasad S. Adusumilli, H. Richard Alexander, Paul Baas, Fabrizio Bardelli, Angela Bononi, Raphael Bueno, Emanuela Felley‐Bosco, Françoise Galateau-Sallé, David M. Jablons, Aaron S. Mansfield, Michael Minaai, Marc de Perrot, Patricia A. Pesavento, Valerie W. Rusch, David T. Severson, Emanuela Taioli, Anne S. Tsao, Gavitt A. Woodard, Haining Yang, Marjorie G. Zauderer, Harvey I. Pass - CA A Cancer Journal for Clinicians 2019 被引用: 456

  18. A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors

    著者: Aaron S. Mansfield, David S. Hong, Christine L. Hann, Anna F. Farago, Himisha Beltran, Saiama N. Waqar, Andrew Hendifar, Lowell Anthony, Matthew H. Taylor, Alan H. Bryce, Scott T. Tagawa, Karl D. Lewis, Jiaxin Niu, Christine H. Chung, James M. Cleary, M. Rossi, Carrianne Ludwig, Ricardo Santoyo Valenzuela, Yan Luo, Rahul Aggarwal - npj Precision Oncology 2021 被引用: 74

  19. Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer

    著者: Aaron S. Mansfield, MC Aubry, Justin C. Moser, Susan M. Harrington, Roxana Dronca, S. S. Park, Haidong Dong - Annals of Oncology 2016 被引用: 336

  20. Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

    著者: Narjust Duma, Azzouqa Abdel-Ghani, Siddhartha Yadav, Katherine P. Hoversten, Clay T. Reed, Andrea Sitek, Elizabeth Ann L. Enninga, Jonas Paludo, Jesus Vera Aguilera, Konstantinos Leventakos, Yanyan Lou, Lisa A. Kottschade, Haidong Dong, Aaron S. Mansfield, Rami Manochakian, Alex A. Adjei, Roxana Dronca - The Oncologist 2019 被引用: 134

  21. CX3CR1 identifies PD-1 therapy–responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy

    著者: Yiyi Yan, Siyu Cao, Xin Liu, Susan M. Harrington, Wendy Bindeman, Alex A. Adjei, Jin Sung Jang, Jin Jen, Ying Li, Pritha Chanana, Aaron S. Mansfield, Sean S. Park, Svetomir N. Markovic, Roxana Dronca, Haidong Dong - JCI Insight 2018 被引用: 183

  22. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study

    著者: Vivek Subbiah, Mimi I. Hu, Aaron S. Mansfield, Matthew H. Taylor, Martin Schüler, Viola W. Zhu, Julien Hadoux, Giuseppe Curigliano, Lori J. Wirth, Justin F. Gainor, Guzmán Alonso, Douglas Adkins, Yann Godbert, Myung‐Ju Ahn, Philippe A. Cassier, Byoung Chul Cho, Chia‐Chi Lin, Alena Zalutskaya, Teresa Barata, Peter C. Trask, Astrid Scalori, Walter Bordogna, Sebastian Heinzmann, Marcia S. Brose - Thyroid 2023 被引用: 55

  23. Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma

    著者: Peter W. Szlosarek, Ben Creelan, Thomas Sarkodie, Luke Nolan, Paul Taylor, Olga Olevsky, Federica Grosso, Diego Cortinovis, Meenali Chitnis, Amy Roy, David Gilligan, Hedy L. Kindler, Dionysis Papadatos-Pastos, Giovanni Luca Ceresoli, Aaron S. Mansfield, Anne S. Tsao, Kenneth J. O’Byrne, Anna K. Nowak, Jeremy Steele, Michael Sheaff, Chiung‐Fang Shiu, Chih‐Ling Kuo, Amanda Johnston, John S. Bomalaski, Marjorie G. Zauderer, Dean A. Fennell, ATOMIC-Meso Study Group, Igor I. Rybkin, Christian Rolfo, Melanie Mackean, Nicola Steele, K. Franks, P. Nicholas Shaw, Michael Lind, Sunil Upadhyay, Thomas John, Christos S. Karapetis, Ratnesh Kumar Srivastav, Manlio Mencoboni, Antonio Chella, Nicoletta Zilembo, Filippo de Marinis, Maria Giulia Stella, Inn‐Wen Chong, Chin‐Chou Wang - JAMA Oncology 2024 被引用: 52

  24. ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance

    著者: Jacob J. Orme, Khalid Jazieh, Tiancheng Xie, Susan M. Harrington, Xin Liu, Matthew K. Ball, Benjamin J. Madden, M. Cristine Charlesworth, Tariq U. Azam, Fabrice Lucien, Bharath Wootla, Yanli Li, José C. Villasboas, Aaron S. Mansfield, Roxana Dronca, Haidong Dong - OncoImmunology 2020 被引用: 126